NÖK Therapeutics is a biotechnology company that offers NK cell therapies to deepen remissions and drive cures in high-relapse cancers.
NÖK Therapeutics has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
NÖK Therapeutics is headquartered in Cranberry Twp, United States.
NÖK Therapeutics is a biotechnology company that offers NK cell therapies to deepen remissions and drive cures in high-relapse cancers.
NÖK Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NÖK Therapeutics — Funding & Investors." VCBacked, October 24, 2025, https://www.vcbacked.co/company/nk-therapeutics. Accessed August 16, 2026.
VCBacked. (2025). NÖK Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/nk-therapeutics
{{cite web |title=NÖK Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nk-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated